HOFER, M., M. POSPÍŠIL, Ladislav DUŠEK, Z. HOFEROVÁ a D. KOMŮRKOVÁ. IB-MECA, an Adenosine A3 Receptor Agonist, Does Not Influence Survival of Lethally gamma-Irradiated Mice. Physiological Research. Praha: Fyziologický ústav AV ČR, roč. 61, č. 6, s. 649-654. ISSN 0862-8408. 2012.
Další formáty:   BibTeX LaTeX RIS
Základní údaje
Originální název IB-MECA, an Adenosine A3 Receptor Agonist, Does Not Influence Survival of Lethally gamma-Irradiated Mice
Autoři HOFER, M. (203 Česká republika, garant), M. POSPÍŠIL (203 Česká republika), Ladislav DUŠEK (203 Česká republika, domácí), Z. HOFEROVÁ (203 Česká republika) a D. KOMŮRKOVÁ (203 Česká republika).
Vydání Physiological Research, Praha, Fyziologický ústav AV ČR, 2012, 0862-8408.
Další údaje
Originální jazyk angličtina
Typ výsledku Článek v odborném periodiku
Obor Genetika a molekulární biologie
Stát vydavatele Česká republika
Utajení není předmětem státního či obchodního tajemství
WWW URL
Impakt faktor Impact factor: 1.531
Kód RIV RIV/00216224:14110/12:00063449
Organizační jednotka Lékařská fakulta
UT WoS 000314138600011
Klíčová slova anglicky Mouse; IB-MECA; Adenosine A3 receptor agonist; Lethal gamma-irradiation; Survival
Příznaky Recenzováno
Změnil Změnila: Ing. Mgr. Věra Pospíšilíková, učo 9005. Změněno: 16. 4. 2013 16:44.
Anotace
In our previous studies, IB-MECA, an adenosine A3 receptor agonist, was found to stimulate proliferation of hematopoietic progenitor and precursor cells in mice. This property of IB-MECA was considered to be responsible for its ability to support regeneration of suppressed hematopoiesis after irradiation with sublethal doses of gamma-rays when the drug was given in a postirradiation treatment regimen. This study was aimed at assessing the ability of IB-MECA to influence a 30-day survival of lethally irradiated mice. In a series of experiments, IB-MECA was administered following various lethal radiation doses in various numbers of drug doses and various administration routes. Though in some of these experiments a moderate increase in 30-day survival was observed in IB-MECA-treated mice, the differences in comparison with the controls were not significantly different. It can be inferred from these results and those of previous studies assessing the effects of IB-MECA after sublethal radiation doses that IB-MECA can probably influence only a substantially preserved hematopoiesis like that remaining after sublethal irradiation. Future studies should be aimed at evaluation of the abilities of IB-MECA to influence post-irradiation survival when administered as a part of combined treatment regimens.
VytisknoutZobrazeno: 19. 4. 2024 13:31